Nanexa AB

About Nanexa AB

Nanexa is a pharmaceutical company developing parenteral products based on the proprietary and innovative drug delivery system PharmaShell® – the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. Nanexa develops its own products and also has collaboration agreements with several pharma companies, among others AZ and Novo Nordisk

Read more Show less
Certifications
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Sweden
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
  • Website
  • Virdings Allé 32, 75450, Uppsala, Sweden
Show contact info Hide contact info

Products from Nanexa AB (1)

  • Liraglutide monthly Depot

    Product Liraglutide monthly Depot

    Nanexa has a long acting injectable version of Liraglutide under development. The goal is to develop a once monthly injectable of Liraglutide. The project is presently in Phase I

Nanexa AB Resources (1)